symbol,statement_type,period_end,line_item,value
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.049563
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Normalized EBITDA,543441000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,380595000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,38161000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,1355478000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,EBITDA,543441000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,EBIT,505280000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Net Interest Income,-104838000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Interest Expense,104838000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Interest Income,
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Normalized Income,380595000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,380595000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Total Expenses,3189260000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Diluted Average Shares,19165740.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Basic Average Shares,19165740.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Diluted EPS,20.14
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Basic EPS,20.14
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,385998000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,385998000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Net Income,385998000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,385998000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Net Income Extraordinary,5403000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,380595000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Tax Provision,19847000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Pretax Income,400442000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,45458000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Other Special Charges,
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Write Off,
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-104838000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Total Other Finance Cost,
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,104838000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Operating Income,459822000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Operating Expense,1833782000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Other Operating Expenses,300866000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,38161000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Amortization,
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,38161000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Research And Development,
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Selling General And Administration,1169717000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,1169717000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Gross Profit,2293604000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Cost Of Revenue,1355478000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Total Revenue,3649082000.0
NATHBIOGEN.NS,income,2025-03-31 00:00:00,Operating Revenue,3649082000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.05106
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Normalized EBITDA,504883000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Total Unusual Items,0.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,361697000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,32612000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,1335722000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,EBITDA,504883000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,EBIT,472271000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Net Interest Income,-91112000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Interest Expense,91112000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Interest Income,3224000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Normalized Income,361697000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,361697000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Total Expenses,2860244000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,105906000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Diluted Average Shares,18565370.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Basic Average Shares,18565370.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Diluted EPS,21.34
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Basic EPS,21.34
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,396185000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,396185000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Net Income,396185000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,396185000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Net Income Extraordinary,34488000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,361697000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Tax Provision,19462000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Pretax Income,381159000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,6266000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Special Income Charges,0.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Other Special Charges,-34498000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Write Off,248000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-91112000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Total Other Finance Cost,5761000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,91112000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,3224000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Operating Income,466005000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Operating Expense,1524522000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Other Operating Expenses,279395000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,32612000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Amortization,16056000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,32612000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Research And Development,112763000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Selling General And Administration,930007000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,930007000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,General And Administrative Expense,72858000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,34589000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Gross Profit,1990527000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Cost Of Revenue,1335722000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Total Revenue,3326249000.0
NATHBIOGEN.NS,income,2024-03-31 00:00:00,Operating Revenue,3326249000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,-17151.3
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.0323
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Normalized EBITDA,488030000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Total Unusual Items,-531000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-531000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,350114000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,30123000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,1146123000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,EBITDA,487499000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,EBIT,457376000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Net Interest Income,-103408000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Interest Expense,95733000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Interest Income,179000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Normalized Income,350627848.7
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,350114000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Total Expenses,2553275000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,94657000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Diluted Average Shares,19004000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Basic Average Shares,19004000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Diluted EPS,18.43
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Basic EPS,18.43
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,350114000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,350114000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Net Income,350114000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,350114000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Net Income Extraordinary,0.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,350114000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Tax Provision,11529000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Pretax Income,361643000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,989000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Special Income Charges,-531000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Other Special Charges,-49000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Write Off,580000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-103408000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Total Other Finance Cost,7854000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,95733000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,179000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Operating Income,460362000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Operating Expense,1407152000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Other Operating Expenses,723372000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,30123000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Amortization,16409000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,13714000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Research And Development,93713000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Selling General And Administration,290877000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,234072000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,General And Administrative Expense,56805000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,30988000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Gross Profit,1867514000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Cost Of Revenue,1146123000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Total Revenue,3013637000.0
NATHBIOGEN.NS,income,2023-03-31 00:00:00,Operating Revenue,3013637000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-265947000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.3
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Normalized EBITDA,384247000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Total Unusual Items,-886490000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-886490000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-673853000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,30841000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,1239684000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,EBITDA,-502243000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,EBIT,-533084000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Net Interest Income,-95512000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Interest Expense,101253000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Interest Income,10926000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Normalized Income,-53310000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-673853000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Total Expenses,2437505000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,114416000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Diluted Average Shares,19004000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Basic Average Shares,19004000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Diluted EPS,-35.55
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Basic EPS,-35.55
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,-673853000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,-673853000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Net Income,-673853000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,-673853000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Net Income Extraordinary,0.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,-673853000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Tax Provision,39516000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Pretax Income,-634337000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,973000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Special Income Charges,-886490000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Other Special Charges,886415000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Write Off,75000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,-95512000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Total Other Finance Cost,5185000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,101253000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,10926000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Operating Income,346100000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Operating Expense,1197821000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Other Operating Expenses,530441000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,30841000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Amortization,16055000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,14786000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Research And Development,88852000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Selling General And Administration,264603000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,198149000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,General And Administrative Expense,66454000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,30344000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Gross Profit,1543921000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Cost Of Revenue,1239684000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Total Revenue,2783605000.0
NATHBIOGEN.NS,income,2022-03-31 00:00:00,Operating Revenue,2783605000.0
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Total Unusual Items,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,EBITDA,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,EBIT,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Net Interest Income,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Interest Expense,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Interest Income,12136000.0
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Normalized Income,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Total Expenses,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,151241000.0
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Diluted Average Shares,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Basic Average Shares,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Diluted EPS,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Basic EPS,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Net Income,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Net Income Extraordinary,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Tax Provision,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Pretax Income,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Special Income Charges,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Other Special Charges,-718000.0
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Write Off,809000.0
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Total Other Finance Cost,9638000.0
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,12136000.0
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Operating Income,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Operating Expense,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Amortization,15978718.0
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Research And Development,91541000.0
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Selling General And Administration,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,General And Administrative Expense,50918000.0
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,30778000.0
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Gross Profit,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Total Revenue,
NATHBIOGEN.NS,income,2021-03-31 00:00:00,Operating Revenue,
